Besides a known and active role of IL-6 and TGF-β signalling in the pathogenesis of SSc, there is increasing evidence that also Th-2 cytokines: IL-4 and IL-13, are involved in the pathology of SSc (65, 66). The gene discussed is IL13; the disease is systemic sclerosis.